CAPITAL STOCK (Details)				1 Months Ended	3 Months Ended
	Dec. 17, 2019 USD ($) shares	Nov. 15, 2019 USD ($) $ / shares shares	Oct. 31, 2019 $ / shares	Oct. 31, 2019 $ / shares	Dec. 31, 2019 USD ($) $ / shares shares	Sep. 30, 2019 $ / shares shares
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Reverse stock split			0.025	0.025
Common stock, par value | $ / shares			$ 0.001	$ 0.001	$ 0.001	$ 0.001
Number of warrants outstanding					2,692,798	263,592
Offering
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Common stock issued in private placement, net of offering costs (in shares)		2,285,000
Number of common stock called by warrants	2,627,750	2,285,000
Number of common shares that each warrant has right to purchase		1
Exercise price of warrants (in dollars per share) | $ / shares		$ 5.25			$ 5.60
Public offering price for each share together with warrant | $ / shares		$ 5.25
Additional number of common stock called by warrants		342,750
Warrants exercisable expiration period		45 days
Gross proceeds of offering before underwriter discounts, commissions and other offering expenses | $		$ 12,000,000
Net proceeds from offering after deducting underwriting fees and other expense | $		$ 10,500,000
Minimum exercise price | $ / shares		$ 1.47
Beneficial Ownership Limitation (as a percent)		4.99%
Beneficial Ownership Limitation, at the election of the holder (as a percent)		9.99%
Prior notice period to increase beneficial ownership		61 days
Number of warrants outstanding					8,375
Amount of common shares issued under underwriters partial exercise of over-allotment option | $	$ 3,428
Incremental change in fair value of warrants | $					$ 2,842